VR Logo

Lupin Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1983

Chairman: Manju D Gupta

Managing Director: Nilesh Deshbandhu Gupta

Group: Lupin

Listing: NSE: LUPIN, BSE: 500257

Headquarters: Mumbai, Maharashtra

Website: www.lupinworld.com

Key Facts

Market cap: R 40,451.46 Cr

Revenue (TTM): R 16,953.62 Cr

Earnings (TTM): R -369.14 Cr

Cash: R 3,097.06 Cr

Total Debt: R 8,496.15 Cr

Promoters' ownership: 46.92%

Liquidity: High

52 Week range: R 504.75 - 906.35

Face value: R2.00

Shares outstanding: 45,30,60,010

10 Years Aggregate:

  • CFO: 15,170.65 Cr
  • EBITDA: 26,706.93 Cr
  • Net Profit: 13,808.48 Cr

Stock Performance

Time Period Lupin S&P BSE Sensex S&P BSE Healthcare
YTD16.73-25.6515.56
1 month10.71-2.252.59
3 months27.70-25.506.76
1 Year18.05-21.5716.76
3 Years-10.910.112.02
5 Years-12.441.87-1.90
10 Years9.426.4211.37
As on 22-May-2020
Year Lupin S&P BSE Sensex S&P BSE Healthcare
2019-9.2714.38-3.55
2018-4.595.87-5.89
2017-40.4827.910.49
2016-19.421.95-12.88
201528.55-5.0315.06
201455.8029.8947.43
201347.748.9822.55